Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply

참고문헌 (6)

1. Ahn Young Eun, "Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis", Gut and Liver, 15(2), pp.284~294 (2021), 거트앤리버 소화기연관학회협의회[DOI]
2. Woo HY, "New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis", Clin Mol Hepatol, 21, pp.115~121 (2015)
3. Xin Y, "Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma", Front Immunol, 13, pp.929141~ (2022)
4. He M, "Sorafenib plus hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin vs sorafenib alone for hepatocellular carcinoma with portal vein invasion : a randomized clinical trial", JAMA Oncol, 5, pp.953~960 (2019)
5. Lyu N, "Hepatic arterial infusion of oxaliplatin plus fluorouracil", leucovorin vs. sorafenib for advanced hepatocellular carcinoma, 2018, pp.69, 60~69
6. Chu Kevin Ka-Wan, "Expanding Indications for Liver Transplant: Tumor and Patient Factors", Gut and Liver, 15(1), pp.19~30 (2021), 거트앤리버 소화기연관학회협의회[DOI]

관련 논문AI추천